Back in 2012 Eytani Ganot, a toddler, was diagnosed with muscular dystrophy. Like in so many cases this was a crippling blow to the boy’s family. Shortly after the diagnosis however the boy’s father, Ilan, made a truly inspirational decision. Ganot decided to quit his high paying job and found a brand new company dedicated to finding a cure for his son. That is exactly how Solid Ventures became a biomedical research company with a mission to save lives.
Now, nearly 2 years after the diagnosis, Solid Ventures has had multiple clinical studies and trials with some of the world’s largest pharmaceutical companies for various treatments. One of the more promising results thus far has been the development of a new gene therapy tool to help treat or reduce the effects of muscular dystrophy. Given the short time of development this is a truly inspiring story of a father’s never ending love and desire to make the world better.
In addition to developing various treatment systems for muscular dystrophy the company is also developing multiple wearable devices to help improve the lives of those suffering from muscular dystrophy. Despite having absolutely no medical background or training, Ganot has managed to make his startup medical research company into quite a success in his quest to help his son. Ganot regularly answers the question “how did you do it?” with a simple but powerful answer, “I have to try” he says. As progress continues and the research becomes more and more advanced Ganot is proud to know that his son will receive any possible treatment that shows promise of being successful.
The entire story is heartwarming and it is truly spectacular to see just how far a father will go for his son. Ganot managed to completely change his life in a matter of months to create what has become one of the world’s leading research companies, all in order to do whatever he can to save his son. Ganot hopes that he’ll see a cure or successful treatment for his son in the coming years, and he is hopeful that Solid Ventures will be able to positively impact millions of lives for future muscular dystrophy cases as well.